InfuSystem Holdings (INFU) Non Operating Interest Expenses (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Non Operating Interest Expenses came in at $300000.0 in Q2 2026, down 25.0% on a YoY basis from $400000.0 in Q2 2025, and little changed quarter-over-quarter from $300000.0 in Q1 2026.
Powered by 
Analysis
InfuSystem Holdings (INFU) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has reported Non Operating Interest Expenses for 17 consecutive years, with $300000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses fell 25.0% year-over-year to $300000.0; the trailing twelve-month figure through Jun 2026 stood at $1.2 million (down 26.48% YoY), and the FY2025 full-year result was $1.3 million, down 27.78% from the prior year.
- Non Operating Interest Expenses was little changed at $300000.0 in Q2 2026 per INFU's latest filing, from $300000.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $620000.0 in Q2 2023 and bottomed at $261000.0 in Q4 2025.
- Historically, Non Operating Interest Expenses has averaged $413722.2 across 5 years, with a median of $400000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Non Operating Interest Expenses surged 97.45% in 2023, then tumbled 34.0% in 2025.
- Over 5 years, Non Operating Interest Expenses stood at $402000.0 in 2022, then increased by 24.38% to $500000.0 in 2023, then decreased by 23.2% to $384000.0 in 2024, then plunged by 32.03% to $261000.0 in 2025, then advanced by 14.94% to $300000.0 in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $300000.0, $300000.0, and $261000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.96 Bn | 11.27 Bn | 1.16 Bn | 150.26 Mn |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn | 18.15 Mn |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 113.39 Mn |
| 4 | Concentra Group Holdings Parent | 4.29 Bn | 4.13 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.58 Bn | 2.16 Bn | - | - |
| 6 | Pediatrix Medical | 2.14 Bn | 1.74 Bn | - | 8.17 Mn |
| 7 | Progyny | 2.11 Bn | 1.88 Bn | 89.30 Mn | - |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | - |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 3.21 Mn |
| 10 | InfuSystem Holdings | 242.16 Mn | 241.19 Mn | 21.41 Mn | 300,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 261,000.00 |
| Sep 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 336,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 620,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 402,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 314,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 491,000.00 |
| Sep 30, 2021 | 300,000.00 |